Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIQ


Primary Symbol: IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc > DLBCL trial
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(28)
•••
Comment by variouson Mar 24, 2021 3:12pm
131 Views
Post# 32868239

RE:RE:RE:RE:RE:DLBCL trial

RE:RE:RE:RE:RE:DLBCL trial
Biotech010 wrote: they updated their website, lots of useful info on the COVID program and why its taking longer

https://www.imv-inc.com/product-pipeline/dpx-covid-19


What? LOL that content you posted hasn't been updated for nearly 9 months. The website in general hasn't been updated in a long time. Oh boy you work for imv don't ya? I feel sorry for you that they're making you do this schilling. Crummy company with crummy management. There's a reason active analysts are cutting price targets on this turd. For a company of this size consistently missing their own deadlines is a HUGE red flag.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities